PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.44 - 1.45
1.18 - 2.36
61.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
26.04%
Revenue growth above 1.5x 1097.HK's 2.99%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
26.47%
Gross profit growth under 50% of 1097.HK's 78.50%. Michael Burry would be concerned about a severe competitive disadvantage.
16.15%
EBIT growth similar to 1097.HK's 17.84%. Walter Schloss might infer both firms share similar operational efficiencies.
24.41%
Operating income growth above 1.5x 1097.HK's 16.01%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
13.43%
Net income growth 1.25-1.5x 1097.HK's 10.61%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
15.79%
EPS growth at 75-90% of 1097.HK's 19.82%. Bill Ackman would push for improved profitability or share repurchases to catch up.
15.79%
Diluted EPS growth at 75-90% of 1097.HK's 19.82%. Bill Ackman would expect further improvements in net income or share count reduction.
0.75%
Share reduction more than 1.5x 1097.HK's 11.64%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.75%
Diluted share reduction more than 1.5x 1097.HK's 11.64%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
11.35%
Positive OCF growth while 1097.HK is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-12.85%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-13.79%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
1379.14%
Positive 5Y CAGR while 1097.HK is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
551.89%
Positive 3Y CAGR while 1097.HK is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-122.95%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
56.99%
Positive OCF/share growth while 1097.HK is negative. John Neff might see a comparative advantage in operational cash viability.
44.35%
Positive 3Y OCF/share CAGR while 1097.HK is negative. John Neff might see a big short-term edge in operational efficiency.
-206.81%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
77.04%
5Y net income/share CAGR 1.25-1.5x 1097.HK's 54.55%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
-0.95%
Negative 3Y CAGR while 1097.HK is 56.67%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
-36.08%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-28.34%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
40.22%
Inventory growth well above 1097.HK's 3.29%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.35%
Positive asset growth while 1097.HK is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-8.73%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
53.68%
We have some new debt while 1097.HK reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-0.18%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.